Metalyst Forgings Ltd: Intrinsic Value & Share Price Analysis

Last Updated: May 17, 2025, 4:39 am

All Competitor Stocks of Metalyst Forgings Ltd

Last Updated: August 1, 2025, 5:05 pm

Below is a detailed analysis of the quarterly data for Metalyst Forgings Ltd based on the most recent figures (Jun 2023) and their trends compared to the previous period:

• For Sales, as of Jun 2023, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 63.00 Cr. (Mar 2023) to 67.00 Cr., marking an increase of 4.00 Cr..
• For Expenses, as of Jun 2023, the value is 67.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 64.00 Cr. (Mar 2023) to 67.00 Cr., marking an increase of 3.00 Cr..
• For Operating Profit, as of Jun 2023, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 0.00 Cr..
• For OPM %, as of Jun 2023, the value is -1.00%. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded -1.00%.
• For Other Income, as of Jun 2023, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 0.00 Cr..
• For Interest, as of Jun 2023, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2023, the value is 61.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 61.00 Cr..
• For Profit before tax, as of Jun 2023, the value is -62.00 Cr.. The value appears to be declining and may need further review. It has decreased from -61.00 Cr. (Mar 2023) to -62.00 Cr., marking a decrease of 1.00 Cr..
• For Tax %, as of Jun 2023, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 0.00%.
• For Net Profit, as of Jun 2023, the value is -62.00 Cr.. The value appears to be declining and may need further review. It has decreased from -61.00 Cr. (Mar 2023) to -62.00 Cr., marking a decrease of 1.00 Cr..
• For EPS in Rs, as of Jun 2023, the value is -14.15. The value appears to be declining and may need further review. It has decreased from -14.10 (Mar 2023) to -14.15, marking a decrease of 0.05.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: March 6, 2025, 3:30 pm

Last Updated: Unknown

Last Updated: March 14, 2025, 3:15 pm

Below is a detailed analysis of the balance sheet data for Metalyst Forgings Ltd based on the most recent figures (Mar 2024) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2024, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 44.00 Cr..
• For Reserves, as of Mar 2024, the value is -3,830.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -2,569.00 Cr. (Mar 2023) to -3,830.00 Cr., marking a decline of 1,261.00 Cr..
• For Borrowings, as of Mar 2024, the value is 1,647.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 1,646.00 Cr. (Mar 2023) to 1,647.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Mar 2024, the value is 2,702.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,701.00 Cr. (Mar 2023) to 2,702.00 Cr., marking an increase of 1.00 Cr..
• For Total Liabilities, as of Mar 2024, the value is 562.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,821.00 Cr. (Mar 2023) to 562.00 Cr., marking a decrease of 1,259.00 Cr..
• For Fixed Assets, as of Mar 2024, the value is 348.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,321.00 Cr. (Mar 2023) to 348.00 Cr., marking a decrease of 973.00 Cr..
• For CWIP, as of Mar 2024, the value is 141.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 141.00 Cr..
• For Investments, as of Mar 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2024, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 360.00 Cr. (Mar 2023) to 74.00 Cr., marking a decrease of 286.00 Cr..
• For Total Assets, as of Mar 2024, the value is 562.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,821.00 Cr. (Mar 2023) to 562.00 Cr., marking a decrease of 1,259.00 Cr..

However, the Borrowings (1,647.00 Cr.) are higher than the Reserves (-3,830.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

After reviewing the key financial ratios for Metalyst Forgings Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 23, the value is -72.07. This value is below the healthy minimum of 5. It has decreased from -57.97 (Mar 22) to -72.07, marking a decrease of 14.10.
• For Diluted EPS (Rs.), as of Mar 23, the value is -72.07. This value is below the healthy minimum of 5. It has decreased from -57.97 (Mar 22) to -72.07, marking a decrease of 14.10.
• For Cash EPS (Rs.), as of Mar 23, the value is -16.08. This value is below the healthy minimum of 3. It has decreased from -0.53 (Mar 22) to -16.08, marking a decrease of 15.55.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is -579.85. It has decreased from -507.89 (Mar 22) to -579.85, marking a decrease of 71.96.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is -579.85. It has decreased from -507.89 (Mar 22) to -579.85, marking a decrease of 71.96.
• For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 60.06. It has increased from 52.97 (Mar 22) to 60.06, marking an increase of 7.09.
• For PBDIT / Share (Rs.), as of Mar 23, the value is 1.09. This value is below the healthy minimum of 2. It has increased from -0.26 (Mar 22) to 1.09, marking an increase of 1.35.
• For PBIT / Share (Rs.), as of Mar 23, the value is -54.90. This value is below the healthy minimum of 0. It has increased from -57.71 (Mar 22) to -54.90, marking an increase of 2.81.
• For PBT / Share (Rs.), as of Mar 23, the value is -72.07. This value is below the healthy minimum of 0. It has decreased from -57.97 (Mar 22) to -72.07, marking a decrease of 14.10.
• For Net Profit / Share (Rs.), as of Mar 23, the value is -72.07. This value is below the healthy minimum of 2. It has decreased from -57.97 (Mar 22) to -72.07, marking a decrease of 14.10.
• For PBDIT Margin (%), as of Mar 23, the value is 1.80. This value is below the healthy minimum of 10. It has increased from -0.50 (Mar 22) to 1.80, marking an increase of 2.30.
• For PBIT Margin (%), as of Mar 23, the value is -91.40. This value is below the healthy minimum of 10. It has increased from -108.93 (Mar 22) to -91.40, marking an increase of 17.53.
• For PBT Margin (%), as of Mar 23, the value is -119.99. This value is below the healthy minimum of 10. It has decreased from -109.43 (Mar 22) to -119.99, marking a decrease of 10.56.
• For Net Profit Margin (%), as of Mar 23, the value is -119.99. This value is below the healthy minimum of 5. It has decreased from -109.43 (Mar 22) to -119.99, marking a decrease of 10.56.
• For Return on Capital Employeed (%), as of Mar 23, the value is 11.04. This value is within the healthy range. It has decreased from 13.56 (Mar 22) to 11.04, marking a decrease of 2.52.
• For Return On Assets (%), as of Mar 23, the value is -17.23. This value is below the healthy minimum of 5. It has decreased from -11.83 (Mar 22) to -17.23, marking a decrease of 5.40.
• For Long Term Debt / Equity (X), as of Mar 23, the value is -0.13. This value is below the healthy minimum of 0.2. It has increased from -0.15 (Mar 22) to -0.13, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 23, the value is -0.64. This value is within the healthy range. It has increased from -0.73 (Mar 22) to -0.64, marking an increase of 0.09.
• For Asset Turnover Ratio (%), as of Mar 23, the value is 0.13. It has increased from 0.10 (Mar 22) to 0.13, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 23, the value is 0.03. This value is below the healthy minimum of 1.5. It has decreased from 0.05 (Mar 22) to 0.03, marking a decrease of 0.02.
• For Quick Ratio (X), as of Mar 23, the value is 0.01. This value is below the healthy minimum of 1. It has decreased from 0.03 (Mar 22) to 0.01, marking a decrease of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 23, the value is 1.83. This value is below the healthy minimum of 4. It has increased from 1.57 (Mar 22) to 1.83, marking an increase of 0.26.
• For Interest Coverage Ratio (X), as of Mar 23, the value is 3.64. This value is within the healthy range. It has increased from -1.01 (Mar 22) to 3.64, marking an increase of 4.65.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is -184.22. This value is below the healthy minimum of 3. It has increased from -218.19 (Mar 22) to -184.22, marking an increase of 33.97.
• For Enterprise Value (Cr.), as of Mar 23, the value is 1,645.49. It has decreased from 1,653.86 (Mar 22) to 1,645.49, marking a decrease of 8.37.
• For EV / Net Operating Revenue (X), as of Mar 23, the value is 6.29. This value exceeds the healthy maximum of 3. It has decreased from 7.17 (Mar 22) to 6.29, marking a decrease of 0.88.
• For EV / EBITDA (X), as of Mar 23, the value is 347.89. This value exceeds the healthy maximum of 15. It has increased from -1,419.86 (Mar 22) to 347.89, marking an increase of 1,767.75.
• For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 0.04. This value is below the healthy minimum of 1. It has decreased from 0.10 (Mar 22) to 0.04, marking a decrease of 0.06.
• For Price / BV (X), as of Mar 23, the value is 0.00. This value is below the healthy minimum of 1. It has increased from -0.01 (Mar 22) to 0.00, marking an increase of 0.01.
• For Price / Net Operating Revenue (X), as of Mar 23, the value is 0.04. This value is below the healthy minimum of 1. It has decreased from 0.10 (Mar 22) to 0.04, marking a decrease of 0.06.
• For EarningsYield, as of Mar 23, the value is -29.06. This value is below the healthy minimum of 5. It has decreased from -10.80 (Mar 22) to -29.06, marking a decrease of 18.26.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks